Botanical species · safety record
Syzygium cumini
The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Syzygium cumini. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Syzygium cumini (L.) Skeels
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 33 licensed products naming Syzygium cumini as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Proanthocyanidins (condensed tannins)3
- Saponins2
Plant parts
- Leaves3
- Bark1
- Fruit unspecified1
- Stem1
- stalk1
Preparations
- Solvent extraction6
Effect types
- Hemopoietic1
Target tissues
- Blood coagulation1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Proanthocyanidins (condensed tannins) | Leaves | Solvent extraction | 17.3 Percent | Phytochemical screening | No resolvable identifier |
| Proanthocyanidins (condensed tannins) | Bark | Solvent extraction | 30.2 Percent | Phytochemical screening | No resolvable identifier |
| Proanthocyanidins (condensed tannins) | Stem / stalk | Solvent extraction | 32 Percent | Phytochemical screening | No resolvable identifier |
| Saponins | Leaves | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Saponins | Fruit unspecified | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Hemopoietic | Blood coagulation | Leaves | Solvent extraction | — | In vitro | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Mali, S., Borges, R. M. Phenolics, fibre, alkaloids, saponins, and cyanogenic glycosides in a seasonal cloud forest in India. Biochemical Systematics and Ecology, 2003, p. 1221-1246.
- Adhyapak, M.S., Kachole, M.S. Investigation of adverse effects of interactions between herbal drugs and natural blood clotting mechanism. Journal of thrombosis and thrombolysis, 2015. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.